lamivudine has been researched along with Bone Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angarano, G; Bellacosa, C; Coladonato, L; Fasano, M; Grattagliano, V; Lapadula, G; Leone, A; Maggi, P; Montinaro, V; Santantonio, T; Volpe, A | 1 |
| Crespo, M; Curran, A; Domingo, P; Gatell, J; Mallolas, J; Martinez-Rebollar, M; Mateo, GM; Navarro, J; Podzamczer, D; Ribera, E; Saumoy, M | 1 |
1 trial(s) available for lamivudine and Bone Diseases
| Article | Year |
|---|---|
Improvement of BMD after Switching from Lopinavir/R Plus Two Nucleos(T)ide Reverse Transcriptase Inhibitors to Lopinavir/R Plus Lamivudine: OLE-LIP Substudy.
Topics: Adult; Antiretroviral Therapy, Highly Active; Bone Density; Bone Diseases; CD4 Lymphocyte Count; Drug Substitution; Female; HIV Infections; Humans; Lamivudine; Lopinavir; Male; Middle Aged; Reverse Transcriptase Inhibitors; Risk Factors; Viral Load | 2016 |
1 other study(ies) available for lamivudine and Bone Diseases
| Article | Year |
|---|---|
Bone and kidney toxicity induced by nucleotide analogues in patients affected by HBV-related chronic hepatitis: a longitudinal study.
Topics: Adenine; Adult; Aged; Antiviral Agents; Bone Diseases; Drug-Related Side Effects and Adverse Reactions; Female; Glomerular Filtration Rate; Hematuria; Hepatitis B, Chronic; Humans; Hypophosphatemia; Kidney Diseases; Lamivudine; Longitudinal Studies; Male; Middle Aged; Organophosphonates; Proteinuria; Vitamin D Deficiency | 2015 |